Mapping the global landscape for induced pluripotent stem cells from patents and clinical trials

Nat Biotechnol. 2024 Apr;42(4):563-569. doi: 10.1038/s41587-024-02196-1.

Liyang Lyu^#¹, Ye Feng^#¹, Borong Huang^#^{2

3}, Ren-He Xu^{4

5}, Yuanjia Hu^{6

7

8}

¹ State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Macao SAR, China.
² Center of Reproduction, Development & Aging, and Institute of Translational Medicine, Faculty of Health Sciences, University of Macau, Macao SAR, China.
³ Ministry of Education Frontiers Science Center for Precision Oncology, University of Macau, Macao SAR, China.
⁴ Center of Reproduction, Development & Aging, and Institute of Translational Medicine, Faculty of Health Sciences, University of Macau, Macao SAR, China. renhexu@um.edu.mo.
⁵ Ministry of Education Frontiers Science Center for Precision Oncology, University of Macau, Macao SAR, China. renhexu@um.edu.mo.
⁶ State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Macao SAR, China. yuanjiahu@um.edu.mo.
⁷ DPM, Faculty of Health Sciences, University of Macau, Macao SAR, China. yuanjiahu@um.edu.mo.
⁸ Centre for Pharmaceutical Regulatory Sciences, University of Macau, Macao SAR, China. yuanjiahu@um.edu.mo.

^# Contributed equally.

No abstract available

MeSH terms